These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7682953)

  • 1. Human CD5-positive B cells in lymphoid malignancy and connective tissue diseases.
    Youinou P; Mackenzie LE; Lamour A; Mageed RA; Lydyard PM
    Eur J Clin Invest; 1993 Mar; 23(3):139-50. PubMed ID: 7682953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5+ B cells in autoimmune disease and lymphoid malignancy.
    Shirai T; Hirose S; Okada T; Nishimura H
    Clin Immunol Immunopathol; 1991 May; 59(2):173-86. PubMed ID: 1706969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD5 B cells in autoimmunity.
    Talal N; Dauphinee M; Ahmed SA
    Ann N Y Acad Sci; 1992 May; 651():551-6. PubMed ID: 1376075
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of CD5-expressing B cells in health and disease (review).
    Pers JO; Jamin C; Predine-Hug F; Lydyard P; Youinou P
    Int J Mol Med; 1999 Mar; 3(3):239-45. PubMed ID: 10028047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [At the crossroads between B lymphoproliferative syndromes to autoimmune diseases are CD5-positive B-lymphocytes: a new hypothesis].
    Youinou P
    Bull Acad Natl Med; 1999; 183(1):159-69; discussion 170. PubMed ID: 10371774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD5 and CD72 on T and B cell subsets in rheumatoid arthritis and Sjögren's syndrome.
    Jamin C; Lamour A; Pennec YL; Hirn M; Le Goff P; Youinou P
    Clin Exp Immunol; 1993 May; 92(2):245-50. PubMed ID: 7683586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseases.
    Markeljević J; Batinić D; Uzarević B; Bozikov J; Cikes N; Babić-Naglić D; Horvat Z; Marusić M
    J Rheumatol; 1994 Dec; 21(12):2225-30. PubMed ID: 7535356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity-prone B-1 (CD5 B) cells, natural antibodies and self recognition.
    Kasaian MT; Casali P
    Autoimmunity; 1993; 15(4):315-29. PubMed ID: 7511005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-1 cells in systemic autoimmune responses: IgM+, Fc epsilon Rdull B cells are lost during chronic graft-versus-host disease but not in murine AIDS or collagen-induced arthritis.
    Iciek LA; Waldschmidt TJ; Griffiths MM; Brooks KH
    Immunol Invest; 1994 Aug; 23(4-5):293-311. PubMed ID: 7525472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD5-positive B cells at the crossroads of B cell malignancy and nonorgan-specific autoimmunity.
    Youinou P; Pers JO; Jamin C; Lydyard PM
    Pathol Biol (Paris); 2000 Jul; 48(6):574-6. PubMed ID: 10965537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
    Ebo D; DeClerck LS; Bridts CH; Stevens WJ
    In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice.
    Morshed SR; Mannoor K; Halder RC; Kawamura H; Bannai M; Sekikawa H; Watanabe H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2551-61. PubMed ID: 12207339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia.
    Huang JC; Finn WG; Goolsby CL; Variakojis D; Peterson LC
    Am J Clin Pathol; 1999 Jan; 111(1):123-30. PubMed ID: 9894463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic regulation of CD5+ B cells in autoimmune disease and in chronic lymphocytic leukemia.
    Shirai T; Okada T; Hirose S
    Ann N Y Acad Sci; 1992 May; 651():509-26. PubMed ID: 1376072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity.
    Becker H; Weber C; Storch S; Federlin K
    Clin Immunol Immunopathol; 1990 Aug; 56(2):219-25. PubMed ID: 1696188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5 B1 cells in the specificity repertoire to self/non-self antigens.
    Bell CG
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):287S. PubMed ID: 7693521
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoimmunity, autoimmune diseases and lymphoproliferative disorders.
    Caligaris-Cappio F; Bertero MT; Bergui L
    Haematologica; 1994; 79(6):487-92. PubMed ID: 7534743
    [No Abstract]   [Full Text] [Related]  

  • 18. Aberrant T-regulation in rheumatoid arthritis and IgA nephropathy affects CD5+ and CD5- B lymphocytes equally.
    Jones BM; Cheng IK; Wong RW
    Clin Exp Immunol; 1991 Nov; 86(2):212-8. PubMed ID: 1718638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD5+ B lymphocytes and other lymphocyte subsets in primary Sjögren's syndrome.
    van de Merwe JP; van den Beemd MW; Hooijkaas H
    Neth J Med; 1992 Apr; 40(3-4):158-64. PubMed ID: 1376444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoreactive and polyreactive rheumatoid factors produced by in vitro Epstein-Barr virus-transformed peripheral blood and synovial B lymphocytes from rheumatoid arthritis patients.
    Burastero SE; Cutolo M; Dessì V; Celada F
    Scand J Immunol; 1990 Oct; 32(4):347-57. PubMed ID: 1700467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.